PCI Pharma Services – a global contract development and manufacturing organisation (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea.
After purchasing Veolia Water Technologies’ new ORION 2000S RO and CEDI unit, a major manufacturer has been able to expand its production capacity and reduce its water footprint by up to 40%.
Considering the overlapping needs of a drug therapy delivered via wearable injectors, each project benefits from its own specific approach. Portescap’s business development manager for medical applications, Dave Beckstoffer, explains.
CN Bio, a provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, has announced the establishment of a strategic partnership with Pharmaron, a premier R&D service provider for the industry.
Beckman Coulter Life Sciences, a Danaher company, announces the launch of the OptiMATE Gradient Maker, an instrument designed to automate the process of density gradient ultracentrifugation (DGUC).
CARBOGEN AMCIS Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).
Gerresheimer, innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, is now offering complete, silicone-oil- and PFAS-free syringe systems made of glass and cyclic olefin polymer (COP).
Mabtech, a Swedish life science tools company developing immunoassay biochemical tests for research, announces a new highly innovative image-based multiplex platform in close collaboration with research and technology specialist Qamcom.
